David Kirn

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

FDMT

Current role

CEO, Board Member

2013-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	4D Molecular Therapeutics, Inc. (FDMT)	President and Chief Executive Officer	$667,252	—	—	$822,750	$560,597	$744	$2,051,343
2024	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$662,780	—	—	—	$292,662	$53,561	$1,009,004
2023	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$596,640	—	—	$9,278,715	$394,953	$16,500	$10,286,808
2022	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$585,720	—	—	$2,367,000	$321,750	$13,500	$3,287,970
2021	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$570,000	—	—	$4,389,825	$228,000	$13,000	$5,200,825
2020	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$451,189	—	—	—	$237,344	$13,000	$701,533
2019	4D Molecular Therapeutics, Inc. (FDMT)	Chief Executive Officer	$430,000	—	—	—	$111,800	$12,500	$554,300

No earnings-call appearances or filed executive changes recorded yet.